Back
10x Genomics 10K Form
Sell
25
TXG
10x Genomics
Last Price:
$10.35
Seasonality Move:
-10.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TXG News And Ratings
See the #1 stock for the next 7 days that we like better than TXG
TXG Financial Statistics
Sales & Book Value
| Annual Sales: | $610.8M |
|---|---|
| Cash Flow: | $-9.5M |
| Price / Cash Flow: | 57.35 |
| Annual Sales: | $5.81 |
| Price / Book: | 1.78 |
Profitability
| EPS (TTM): | -1.52000 |
|---|---|
| Net Income (TTM): | $-182.6M |
| Gross Margin: | $414.5M |
| Return on Equity: | -25.25% |
| Return on Assets: | -19.54% |
10x Genomics Earnings Forecast
Key 10x Genomics Financial Ratios
-
The Gross Profit Margin over the past 8 years for TXG is 67.86%.
-
The Selling, General & Administrative Expenses for TXG have been equal to 56.38% of Gross Profit Margin.
-
The Research & Development expenses have been 43.34% of Revenue.
-
The Net Earning history of TXG is -29.90% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
10x Genomics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | TXG |
| CUSIP: | 88025U |
| Website: | 10xgenomics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.97 |
| Quick Ratio: | 4.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TXG Technical Analysis vs Fundamental Analysis
Sell
25
10x Genomics (TXG)
is a Sell
Is 10x Genomics a Buy or a Sell?
-
10x Genomics stock is rated a SellThe current 10x Genomics [TXG] share price is $10.34. The Score for TXG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.